UBS AM
ETNB

UBS AM’s 89bio ETNB Stock Holding History

UBS AM’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-241,011
Closed -$3.54M – 3300
2025
Q3 		$3.54M Sell
241,011
-150,399
-38% -$1.53M ﹤0.01% 1522
2025
Q2 		$3.84M Buy
391,410
+122,612
+46% +$1.02M ﹤0.01% 1828
2025
Q1 		$1.95M Buy
268,798
+90,107
+50% +$788K ﹤0.01% 2004
2024
Q4 		$1.4M Buy
178,691
+37,693
+27% +$310K ﹤0.01% 2215
2024
Q3 		$1.04M Buy
140,998
+1,624
+1% +$13.7K ﹤0.01% 2373
2024
Q2 		$1.12M Buy
139,374
+66,674
+92% +$595K ﹤0.01% 2320
2024
Q1 		$846K Buy
72,700
+13,600
+23% +$151K ﹤0.01% 2092
2023
Q4 		$660K Buy
59,100
+6,411
+12% +$58.9K ﹤0.01% 2224
2023
Q3 		$814K Buy
+52,689
New +$884K ﹤0.01% 2059

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS AM's ETNB Position: Q4 2025 in Review

UBS AM sold out of 89bio (ETNB) in Q4 2025, closing a stake of 241,011 shares — an estimated $3.54M sold.

UBS AM first reported a position in ETNB in Q3 2023 and held it in 9 quarters. The position peaked at $3.84M in Q2 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • UBS AM reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • UBS AM sold 241,011 89bio shares in Q4 2025, an estimated $3.54M.
  • UBS AM first reported a position in 89bio in Q3 2023 and held it in 9 quarters.
  • UBS AM's 89bio position peaked at $3.84M in Q2 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on UBS AM's 13F filing for Q4 2025, filed 13 Feb 2026.